| 1-AG | 1-arachidonoylglycerol |
| 1-LG | 1-linoleoyl glycerol |
| 1-OG | 1-oleoyl glycerol |
| 2-AG | 2-arachidonoylglycerol |
| 2-LG | 2-linoleoyl glycerol |
| 2-OG | 2-oleoyl glycerol |
| 5-HEPE | 5-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid; |
| 8,9-DiHETrE | 8,9-dihydroxy-5Z,11Z,14Z-eicosatrienoic acid; |
| 8(9)-EpETrE | 8(9)-epoxy-5Z,11Z,14Z-eicosatrienoic acid; |
| 9(10)-EpODE | 9(10)-epoxy-12Z,15Z-octadecadienoic acid; |
| 11,12-DiHETrE | 11,12-dihydroxy-5Z,8Z,14Z-eicosatrienoic acid; |
| 11(12)-EpETrE | 11(12)-epoxy-5Z,8Z,14Z-eicosatrienoic acid; |
| 12(13)-EpODE | 12(13)-epoxy-10E,15Z-octadecadienoic acid; |
| 12-HEPE | 12-hydroxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid; |
| 13-HODE | 13-hydroxy-9Z,11E-octadecadienoic acid; |
| 13-HpODE | 13-hydroperoxy-9Z,11E-octadecadienoic acid. |
| 14,15-DiHETE | 14,15-dihydroxy-5Z,8Z,11Z,17Z-eicosatetraenoic acid; |
| 14(15)-EpETrE | 14(15)-epoxy-5Z,8Z,11Z-eicosatrienoic acid; |
| 15(16)-EpODE | 15(16)-epoxy-9Z,12Z-octadecadienoic acid; |
| 17,18-DiHETE | 17,18-dihydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid; |
| 19(20)-EpDPE | 19(20)-epoxy-4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid |
| αL-EA | alpha-linolenoyl ethanolamide |
| A-EA | arachidonoyl ethanolamide |
| AEA | anandamide |
| CKD | chronic kidney disease |
| D-EA | docosatetraenoyl ethanolamide |
| DAGL | diacylglycerol lipase |
| DGLA | dihomo-gamma-linolenic aid |
| DGLA-EA | dihomo-gamma-linolenoyl ethanolamide |
| DH-EA | docosahexaenoyl ethanolamide |
| DHA | docosahexaenoic acid |
| ECS | endocannabinoid system |
| EPA | eicosapentaenoic acid |
| FAME | fatty acid methyl esters |
| HDP | Hemodialysis patients |
| L-EA | linoleoyl ethanolamide |
| MAGL | monoacylglycerol lipase |
| NAPE-PLD | N-arachidonoyl phosphatidylethanolamine phospholipase D |
| O-EA | oleoyl ethanolamide |
| P-EA | palmitoyl ethanolamide |
| PMSF | phenylmethanesulfonylfluoride |
| PUFA | polyunsaturated fatty acids |
| S-EA | stearoyl ethanolamide |